名次后缀
发表于 2025-3-27 00:43:52
http://reply.papertrans.cn/39/3883/388212/388212_31.png
Foolproof
发表于 2025-3-27 02:39:20
http://reply.papertrans.cn/39/3883/388212/388212_32.png
过渡时期
发表于 2025-3-27 07:07:01
http://reply.papertrans.cn/39/3883/388212/388212_33.png
暂时过来
发表于 2025-3-27 10:41:59
http://reply.papertrans.cn/39/3883/388212/388212_34.png
免费
发表于 2025-3-27 15:55:36
,Treatment of Hyperthyroidism in Patients with Graves’ Orbitopathy, pathogenetic mechanisms of the disease. Graves’ orbitopathy (GO), the most frequent extrathyroidal manifestation of Graves’ disease, is present in about 25 % of newly diagnosed Graves’ patients, and rarely progresses over time. Neither ATDs nor thyroidectomy appear to affect the natural course of G
流动性
发表于 2025-3-27 19:23:45
,Assessment and Management Plan for Graves’ Orbitopathy, gradual onset of proptosis and lid retraction, usually associated with fat expansion on orbital imaging. In approximately one-third of cases, the disease develops rapidly with significant involvement of one or more extraocular muscles and resultant periocular soft tissue congestion, motility disrup
emulsify
发表于 2025-3-27 22:45:50
http://reply.papertrans.cn/39/3883/388212/388212_37.png
过渡时期
发表于 2025-3-28 02:59:00
http://reply.papertrans.cn/39/3883/388212/388212_38.png
Hyperalgesia
发表于 2025-3-28 07:50:47
http://reply.papertrans.cn/39/3883/388212/388212_39.png
MAPLE
发表于 2025-3-28 14:10:15
,Epidemiology and Genetic Factors in Graves’ Disease and Graves’ Ophthalmopathy, disease development. Our group and others have further focused on thyroid-specific genes such as TSH receptor and thyroglobulin gene and have shown that they play a major role in GD. Genetic studies in GO, however, did not show consistent results. Since the entire risk for GD is not conveyed by gen